v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - ARS ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES      
Net income (loss) for the year $ (145,304) $ 1,359,230 $ (715,266)
Adjustments to reconcile net income to net cash flows provided by operating activities      
Allowances deducted from assets 160,105 99,860 113,817
Depreciation of PP&E 1,533,091 1,312,898 1,559,899
Amortization of intangible assets 234,722 152,940 251,826
Amortization of rights of use assets 278,639 260,674 205,413
Depreciation of Investment properties 2,028    
Impairment of goodwill 15,941    
Disposals of Fixed and intangible assets 147,293 2,217 1,454
Losses from associates and joint ventures 3,742 15,094 5,408
Financial results and others 624,547 (2,418,267) 803,367
Income tax expenses (46,432) 538,237 (968,990)
Income tax paid (15,012) (9,703) (14,670)
Change in operating assets and liabilities, net of effects from purchase of controlled entity      
Increase Trade receivables (224,666) (343,132) (509,799)
Decrease / (Increase) Other receivables (15,709) (106,937) (257,366)
Decrease / (Increase) Inventories 71,370 (8,403) (59,785)
(Decrease) / Increase Trade payables (17,962) 27,494 968,990
Increase Salaries and social security payables 62,144 109,976 207,576
(Decrease) / Increase Other taxes payables (250,817) 85,071 125,970
(Decrease) / Increase Other Liabilities and Provisions (31,862) (9,736) 51,647
Total cash flows from operating activities 2,385,858 1,067,513 1,769,491
CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES      
Payments for PP&E (1,355,061) (457,953) (756,094)
Payments for intangible asset acquisitions (135,574) (60,623) (571,697)
Dividends received from associates 7 1,333 3,449
Proceeds from the sale of PP&E and intangible assets 37,202 7,777 3,308
Payments for acquisition of subsidiary, net of cash acquired (1,304,037) (18,237) (6,466)
Integration of contributions in joint ventures (220)    
Compensation received for acquisition of companies 1,720 4,208  
Proceeds from DFI liquidations 33,850 5,186 69,087
Proceeds from sale of investments not considered as cash and cash equivalents 442,802 438,002 400,610
Payments for investments not considered as cash and cash equivalents (732,319) (424,073) (766,727)
Acquisition of purchase option     (7,150)
Total cash flows used in investing activities (3,011,630) (504,380) (1,631,680)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES      
Proceeds from borrowings 3,959,692 1,573,995 1,111,970
Payment of borrowings (2,583,267) (1,474,844) (654,722)
Repurchase of Notes (15,011) (34,913)  
Payment of interests, DFI and related expenses (514,351) (428,014) (592,904)
Payments of leases liabilities (196,180) (121,016) (126,595)
Transaction with non-controlling interests   (36,164) (1,690)
Dividends paid to non-controlling interests in subsidiaries (17,640) (12,634) (11,516)
Dividends paid (20,286)    
Total cash flows from (used in) financing activities 612,957 (533,590) (275,457)
NET INCREASE IN CASH AND CASH EQUIVALENTS (12,815) 29,543 (137,646)
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR 418,745 457,698 357,294
NET FOREIGN EXCHANGE DIFFERENCES AND RECPAM ON CASH AND CASH EQUIVALENTS 63,120 (68,496) 238,050
CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR $ 469,050 $ 418,745 $ 457,698